✦ LIBER ✦

248 Antitumor activity, pharmacodynamics and toxicity of PX-866 a novel inhibitor of phosphoinositide-3-kinase

✍ Scribed by L. Kirkpatrick; G. Powis; N. Ihle; G. Paine-Murrieta; D. Minion; R. Halter; R. Abraham; P. Wipf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

134 Biological characterization of ETP-4

✍ J.R. Bischoff; J. Pastor; D. Cebrián; S. Martínez; M. Lorenzo; T. Merino; J. Fom 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

434 POSTER Preclinical pharmacokinetic a

✍ K. Culotta; D. Kirkpatrick; J. Covey; C. Schultz; D. Mack; R. Rhea; T. Allen; G. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

185 ICL-CCIC-0019, a Novel and Selective

✍ Trousil, S.; Kaliszczak, M.; Carroll, L.; Aboagye, E.O. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

In vivo antitumor activity of NVP-AEW541

✍ Carlos Garcı́a-Echeverrı́a; Mark A Pearson; Andreas Marti; Thomas Meyer; Juergen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 201 KB

1204 A Phase I study evaluating the phar

✍ R. Kristeleit; D. Sarker; M. Forster; M. Lolkema; D. Olmos; K. Mazina; M.V. Dole 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Human target validation of phosphoinosit

✍ S. NYLANDER; B. KULL; J. A. BJÖRKMAN; J. C. ULVINGE; N. OAKES; B. M. EMANUELSSON 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB